At Osprey Medical, our mission is to improve outcomes in patients with CKD by reducing contrast induced AKI and lowering hospital costs. Osprey’s proprietary technologies reduce the amount of contrast (dye) injected into patients during heart catheterization procedures without compromising X-ray image quality for the physician.
Osprey Medical’s vision is to make angiography safer for patients suffering from Chronic Kidney Disease. Osprey Medical designs, develops, and manufacturers proprietary devices and monitoring systems that reduce the amount of contrast (dye) used during commonly performed heart catheterization procedures like coronary angiography and stenting. Osprey Medical’s core technologies originated from research conducted by Dr. David Kaye at Melbourne’s Baker IDI Heart and Diabetes Institute.